Bausch Health Adds 2 Directors Chosen By Carl Icahn: What Investors Need To Know
Bausch Health Companies Inc (NYSE: BHC) is expanding its board of directors to accommodate two designees from activist investor Carl Icahn’s Icahn Group, which owns 7.83% of the company’s outstanding common stock.